A Cancer Conundrum: Too Many Drug Trials, Too Few Patients … – New York Times
New York Times |
A Cancer Conundrum: Too Many Drug Trials, Too Few Patients …
New York Times Breakthroughs in immunotherapy and a rush to develop profitable new treatments have brought a crush of clinical trials scrambling for patients. |
